Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies, Febit Ink Co-marketing Deal

NEW YORK (GenomeWeb News) – Life Technologies and Febit jointly announced today that they have signed a co-marketing deal, under which the firms will offer Febit's HybSelect sequence capture technology with Life Tech's SOLiD sequencing system.

The firms said that the alliance is aimed at researchers conducting targeted resequencing studies.

Febit's HybSelect system combines microarray-based enrichment with microfluidics on an automated instrument. The system's eight segregated arrays within a single microfluidic biochip enable parallel, hands-off processing of samples, the firms said.

In addition, the companies said that Febit will add several SOLiD sequencing and real-time PCR systems to its Genomic Services Facility at Heidelberg. Febit said that it is now a member of both the SOLiD System and TaqMan Service Provider Programs.

"Our next-generation sequencing facility will take the lead in targeted sequencing of more than 1,000 samples per week," Peer Staehler, chief scientific officer of Febit, said in a statement. He added that the company has "the capability to go from tailor-made target sequence capture to sequencing results in days, both for customers and our own internal development programs."

Last week, Life Technologies and Agilent announced a co-marketing agreement that combines Agilent's SureSelect Target Enrichment System with the SOLiD system.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.